封面
市場調查報告書
商品編碼
1268900

2023-2030 年按類型(實心、空心)、材料(矽、金屬)、應用(皮膚科、藥物輸送)、地區、細分趨勢分列的微針給藥系統市場規模、份額、趨勢分析報告

Microneedle Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Solid, Hollow), By Material (Silicon, Metal), By Application (Dermatology, Drug Delivery), By Region, And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

微針給藥系統市場增長和趨勢:

根據 Grand View Research, Inc. 的最新報告,全球微針給藥系統市場規模從 2023 年到 2030 年的複合年增長率將達到 7.4%,到 2030 年將達到 94%。預計將達到6000萬美元。

對傳統皮下注射更安全替代品的需求不斷增加,以及對微創和無痛給藥意識的增強,預計將推動微針給藥系統的市場增長。 此外,糖尿病患者數量的增加也有望推動市場增長。 例如,據世界衛生組織 (WHO) 估計,到 2021 年,全球約有 4.63 億成年人患有糖尿病,佔世界人口的 9.3%。

與口服和經皮途徑等傳統給藥方法相比,微針具有多項優勢。 研究表明,微針給藥可以提高藥物的吸收、生物利用度和藥效,尤其是對於低水溶性或低滲透性的藥物。 例如,發表在《Journal of Controlled Release》上的一項研究表明,使用微針透皮注射胰島素比皮下注射更有效。

COVID-19 大流行對微針給藥產生了重大影響。 大流行對市場的一個主要影響是對疫苗交付的需求增加。 微針因其易用性、低成本和可能引發強烈免疫反應而被認為是 COVID-19 疫苗的候選遞送方法。 大流行加速了基於微針的疫苗輸送系統的開發,多家公司和學術機構致力於開發 COVID-19 疫苗貼劑。

但是,大流行正在擾亂全球供應鏈並影響微針給藥系統的生產和分銷。 一些製造商難以獲得原材料和零部件,導致供應短缺和價格上漲。

微針給藥系統市場報告要點:

  • 空心微針細分市場在 2022 年佔據了最大的收入份額,因為它最適合用於疫苗和激素治療患者。
  • 預計可溶性微針部分在預測期內將以最快的速度增長,因為微針插入後無需取出,只需一個步驟。
  • 到 2022 年,金屬材料領域的收入份額將最高,其中不銹鋼和鈦是最常用的金屬。
  • 按應用來看,藥物輸送領域在 2022 年佔據了市場主導地位。
  • 由於人們對疫苗接種的認識不斷提高,預計疫苗部分在預測期內將呈現最快的增長速度。
  • 由於中國和印度等新興經濟體存在未開發的機會,預計亞太地區在預測期內將以最快的複合年增長率增長。

內容

第一章調查方法及範圍

  • 市場細分和範圍
    • 類型
    • 材料
    • 申請
    • 區域範圍
    • 估計/預測時間表
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 初步調查的詳細信息
      • 北美的首次採訪數據
      • 歐洲主要訪談數據
      • 來自亞太地區主要訪談的數據
      • 拉丁美洲主要訪談數據
      • MEA 主要訪談數據
  • 信息或數據分析
    • 數據分析模型
  • 市場形成和驗證
  • 模型詳細信息
    • 產品流分析(模型 1)
    • 方法 1:產品流方法
    • 批量價格分析(模型 2)
    • 方法 2:量價分析
  • 次要信息列表
  • 主要信息列表
  • 目的

第 2 章執行摘要

  • 市場前景
  • 細分市場展望
    • 類型展望
    • 材料展望
    • 使用前景
    • 區域展望
  • 競爭考慮

第 3 章微針給藥系統市場變量、趨勢和範圍

  • 市場體系展望
    • 母公司市場展望
    • 相關/補充市場展望
  • 採用和增長前景映射
  • 行業價值鏈分析
    • 報銷框架
  • 市場動態
    • 市場驅動因素分析
      • 對傳統皮下注射的更安全替代品的需求不斷增加
      • 糖尿病患者在世界範圍內不斷增加
      • 技術進步
    • 市場製約因素分析
      • 批准的產品數量有限
      • 與微針相關的並發症/風險
  • 微針給藥系統市場分析工具
    • 行業分析 - 搬運工
      • 供應商的力量
      • 買家的議價能力
      • 更換威脅
      • 新進入者的威脅
      • 競爭公司之間的敵對關係
    • PESTEL 分析
      • 政治形勢
      • 技術情況
      • 經濟狀況
    • 對主要交易和戰略聯盟的分析
    • 市場進入策略

第 4 章微針給藥系統:類型估計和趨勢分析

  • 定義和範圍
    • 固體
    • 中空
    • 溶解
    • 塗層
    • 其他
  • 類型市場份額,2022 年和 2030 年
  • 部門儀表板
  • 按類型分列的全球微針給藥系統市場前景
  • 以下市場規模、預測和趨勢分析,2018-2030 年
    • 固體
    • 中空
    • 溶解
    • 塗層
    • 其他

第 5 章微針給藥系統:材料估算和趨勢分析

  • 材料和範圍
    • 金屬
    • 聚合物
    • 其他
  • 材料市場份額,2022 年和 2030 年
  • 部門儀表板
  • 按材料分列的全球微針給藥系統市場前景
  • 以下市場規模、預測和趨勢分析,2018-2030 年
    • 金屬
    • 聚合物
    • 其他

第 6 章微針給藥系統:應用估算和趨勢分析

  • 定義和範圍
    • 皮膚科
    • 給藥
    • 疼痛管理
    • 癌症治療
    • 提供疫苗
    • 其他
  • 2022 年和 2030 年的應用市場份額
  • 部門儀表板
  • 按應用劃分的全球微針給藥系統市場展望
  • 以下市場規模、預測和趨勢分析,2018-2030 年
    • 皮膚科
    • 荷爾蒙輸送
    • 疼痛管理
    • 癌症治療
    • 提供疫苗
    • 其他

第 7 章微針給藥系統市場:區域估計和趨勢分析

  • 2022 年和 2030 年區域市場份額分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2021 年區域市場份額和主要參與者
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • SWOT 因素分析(政治/法律、經濟/技術)
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 2018-2030 年市場規模、預測、數量和趨勢分析
  • 北美
    • 2018-2030 年市場估計和預測(收入)
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多邊環境協定
    • 沙特阿拉伯
    • 南非
    • 阿拉伯聯合酋長國
    • 科威特

第八章競爭格局

  • 主要市場進入者的近期趨勢和影響分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商情況
    • 主要分銷商和渠道合作夥伴名單
    • 主要客戶
    • 2021 年主要公司市場份額分析
    • Raphas
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Novartis International AG
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Becton, Dickinson and Company
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • B. Braun
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Nanopass technologies limited
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Termo
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Smiths Medical
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Cardinal Health
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 3M
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68039-555-9

Microneedle Drug Delivery Systems Market Growth & Trends:

The global microneedle drug delivery systems market size is expected to reach USD 9.46 billion by 2030, registering a CAGR of 7.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. Growing demand for safer alternatives to conventional hypodermic injection and increasing awareness about minimally invasive and pain-free administration of drugs is expected to boost the market growth for microneedle drug delivery systems. Furthermore, increasing cases of diabetes are also expected to boost the market growth. For instance, as per the estimates of the World Health Organization (WHO) in 2021, approximately 463 million adults were living with diabetes, worldwide, representing 9.3% of the global population.

Microneedles offer several advantages over traditional drug delivery methods, such as oral or transdermal routes. Studies have shown that drug delivery by microneedles can improve drug absorption, bioavailability and efficacy, especially for drugs with poor water solubility or low permeability. For instance, a study published in "Journal of Controlled Release" showed that transdermal delivery of insulin using microneedles was more effective than subcutaneous injection.

The COVID-19 pandemic had a significant impact on drug delivery by microneedles. The major impact of the pandemic on the market was the increased demand for vaccine delivery. Microneedles have been explored as a potential delivery method for the COVID-19 vaccines due to their ease of use, low cost, and potential to induce a strong immune response. The pandemic has accelerated development of the microneedle-based vaccine delivery systems, with several companies and academic institutions working on COVID-19 vaccine patches.

However, the pandemic has also disrupted global supply chains, which has affected the production and distribution of microneedle-based drug delivery systems. Some manufacturers have faced challenges in obtaining raw materials and components, which has resulted in supply shortages and increased prices.

Microneedle Drug Delivery Systems Market Report Highlights:

  • The hollow microneedle segment accounted for the largest revenue share in 2022, since they are considered ideal for the use of vaccine and hormonal therapy patients
  • Dissolving microneedle segment is expected to grow at the fastest rate during the forecast period, as it only requires one step, the microneedle needs not be removed after insertion
  • The metal material segment accounted for the highest revenue share in 2022; stainless steel and titanium are the most frequently employed metals
  • By application, drug delivery segment dominated the market in 2022
  • The vaccine segment is expected to experience the fastest growth rate during the forecast period due to the increased awareness of vaccination among populations
  • Asia Pacific is anticipated to grow at the fastest CAGR during the forecast period due to the presence of untapped opportunities in the emerging economies of China and India

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Material
    • 1.1.3. Application
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
      • 1.6.1.1. Commodity flow analysis (Model 1)
      • 1.6.1.2. Approach 1: Commodity flow approach
      • 1.6.1.3. Volume price analysis (Model 2)
      • 1.6.1.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Material outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Microneedle Drug Delivery Systems Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. The increasing demand for safer substitute to conventional hypodermic injections
      • 3.4.1.2. Increase in diabetic cases across the globe
      • 3.4.1.3. Technological advancements
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Limited number of approved products
      • 3.4.2.2. Complications/risks associated with microneedles
  • 3.5. Microneedle Drug Delivery Systems Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Microneedle Drug Delivery Systems : Type Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Solid
    • 4.1.2. Hollow
    • 4.1.3. Dissolving
    • 4.1.4. Coated
    • 4.1.5. Others
  • 4.2. Type Market Share, 2022 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Microneedle Drug Delivery Systems Market by Type Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Solid
      • 4.5.1.1. Solid market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Hollow
      • 4.5.2.1. Hollow market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Dissolving
      • 4.5.3.1. Dissolving market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.4. Coated
      • 4.5.4.1. Coated market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Microneedle Drug Delivery Systems : Material Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Silicon
    • 5.1.2. Metal
    • 5.1.3. Polymer
    • 5.1.4. Others
  • 5.2. Material Market Share, 2022 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Microneedle Drug Delivery Systems Market by Material Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Silicon
      • 5.5.1.1. Silicon market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Metal
      • 5.5.2.1. Metal market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. Polymer
      • 5.5.3.1. Polymer market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Microneedle Drug Delivery Systems : Application Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Dermatology
    • 6.1.2. Drug delivery
    • 6.1.3. Pain management
    • 6.1.4. Cancer therapy
    • 6.1.5. Vaccine delivery
    • 6.1.6. Others
  • 6.2. Application Market Share, 2022 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Microneedle Drug Delivery Systems Market by Application Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030for the following
    • 6.5.1. Dermatology
      • 6.5.1.1. Dermatology market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Hormone delivery
      • 6.5.2.1. Hormone delivery market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Pain management
      • 6.5.3.1. Pain management market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.4. Cancer therapy
      • 6.5.4.1. Cancer therapy market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.5. Vaccine delivery
      • 6.5.5.1. Vaccine delivery market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.6. Others
      • 6.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Microneedle Drug Delivery Systems Market: Regional Estimates & Trend Analysis

  • 7.1. Regional market share analysis, 2022 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2021
    • 7.4.1. North America
    • 7.4.2. Europe
    • 7.4.3. Asia Pacific
    • 7.4.4. Latin America
    • 7.4.5. Middle East and Africa
  • 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. Asia Pacific
    • 7.5.4. Latin America
    • 7.5.5. Middle East and Africa
  • 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030
  • 7.7. North America
    • 7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. U.S.
      • 7.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. Canada
      • 7.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.8. Europe
    • 7.8.1. UK
      • 7.8.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.2. Germany
      • 7.8.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.3. France
      • 7.8.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.4. Italy
      • 7.8.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.5. Spain
      • 7.8.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.6. Sweden
      • 7.8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.7. Norway
      • 7.8.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.8. Denmark
      • 7.8.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.9. Asia Pacific
    • 7.9.1. China
      • 7.9.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.9.2. Japan
      • 7.9.2.1. Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
    • 7.9.3. India
      • 7.9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.9.4. Australia
      • 7.9.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.9.5. Thailand
      • 7.9.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.9.6. South Korea
      • 7.9.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.10. Latin America
    • 7.10.1. Brazil
      • 7.10.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.10.2. Mexico
      • 7.10.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.10.3. Argentina
      • 7.10.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.11. MEA
    • 7.11.1. Saudi Arabia
      • 7.11.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.11.2. South Africa
      • 7.11.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.11.3. UAE
      • 7.11.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.11.4. Kuwait
      • 7.11.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2021
    • 8.3.4. Raphas
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Novartis International AG
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Becton, Dickinson and Company
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. B. Braun
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Nanopass technologies limited
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Termo
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Smiths Medical
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Cardinal Health
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. 3M
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Tables
  • Table 2 List of Abbreviation
  • Table 3 North America microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 5 North America microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America microneedle drug delivery systems market, by region, 2018 - 2030 (USD Million)
  • Table 7 U.S. microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 9 U.S. microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 10 Canada microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 12 Canada microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 13 Europe microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 14 Europe microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 15 Europe microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 16 Europe microneedle drug delivery systems market, by region, 2018 - 2030 (USD Million)
  • Table 17 Germany microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 18 Germany microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 19 Germany microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 20 UK microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 21 UK microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 22 UK microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 23 France microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 24 France microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 25 France microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 26 Italy microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 27 Italy microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 28 Italy microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 29 Spain microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 30 Spain microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 31 Spain microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 32 Sweden microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 33 Sweden microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 34 Sweden microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 35 Norway microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 36 Norway microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 37 Norway microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 38 Denmark microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 39 Denmark microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 40 Denmark microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 41 APAC microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 42 APAC microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 43 APAC microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 44 APAC microneedle drug delivery systems market, by region, 2018 - 2030 (USD Million)
  • Table 45 China microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 46 China microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 47 China microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 48 Japan microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 49 Japan microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 50 Japan microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 51 India microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 52 India microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 53 India microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 54 Thailand microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 55 Thailand microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 56 Thailand microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 57 South Korea microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 58 South Korea microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 59 South Korea microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 60 Latin America microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 61 Latin America microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 62 Latin America microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 63 Latin America microneedle drug delivery systems market, by region, 2018 - 2030 (USD Million)
  • Table 64 Brazil microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 65 Brazil microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 66 Brazil microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 67 Mexico microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 68 Mexico microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 69 Mexico microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 70 Argentina microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 71 Argentina microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 72 Argentina microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 73 Middle East and Africa microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 74 Middle East and Africa microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa microneedle drug delivery systems market, by region, 2018 - 2030 (USD Million)
  • Table 77 South Africa microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 78 South Africa microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 79 South Africa microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 83 UAE microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 84 UAE microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 85 UAE microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 86 Kuwait microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 87 Kuwait microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 88 Kuwait microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Microneedle Drug Delivery Systems : market outlook
  • Fig. 9 Microneedle Drug Delivery Systems competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Microneedle drug delivery systems market driver impact
  • Fig. 15 Microneedle drug delivery systems market restraint impact
  • Fig. 16 Microneedle drug delivery systems market strategic initiatives analysis
  • Fig. 17 Microneedle drug delivery systems market: type movement analysis
  • Fig. 18 Microneedle drug delivery systems market: type outlook and key takeaways
  • Fig. 19 Solid market estimates and forecast, 2018 - 2030
  • Fig. 20 Hollow market estimates and forecast, 2018 - 2030
  • Fig. 21 Dissolving market estimates and forecast, 2018 - 2030
  • Fig. 22 Coated market estimates and forecast, 2018 - 2030
  • Fig. 23 Others market estimates and forecast, 2018 - 2030
  • Fig. 24 Microneedle drug delivery systems market: material movement analysis
  • Fig. 25 Microneedle drug delivery systems market: material outlook and key takeaways
  • Fig. 26 Silicon market estimates and forecast, 2018 - 2030
  • Fig. 27 Metal market estimates and forecast, 2018 - 2030
  • Fig. 28 Polymer market estimates and forecast, 2018 - 2030
  • Fig. 29 Others market estimates and forecast, 2018 - 2030
  • Fig. 30 Microneedle drug delivery systems market: application movement analysis
  • Fig. 31 Microneedle drug delivery systems market: application outlook and key takeaways
  • Fig. 32 Dermatology market estimates and forecast, 2018 - 2030
  • Fig. 33 Drug delivery market estimates and forecast, 2018 - 2030
  • Fig. 34 Pain management market estimates and forecast, 2018 - 2030
  • Fig. 35 Cancer therapy market estimates and forecast, 2018 - 2030
  • Fig. 36 Vaccine delivery market estimates and forecast, 2018 - 2030
  • Fig. 37 Others market estimates and forecast, 2018 - 2030
  • Fig. 38 Global microneedle drug delivery systems market: regional movement analysis
  • Fig. 39 Global microneedle drug delivery systems market: regional outlook and key takeaways
  • Fig. 40 Global market share and leading players
  • Fig. 41 North America market share and leading players
  • Fig. 42 Europe market share and leading players
  • Fig. 43 Asia Pacific market share and leading players
  • Fig. 44 Latin America market share and leading players
  • Fig. 45 Middle East & Africa market share and leading players
  • Fig. 46 North America: SWOT
  • Fig. 47 Europe SWOT
  • Fig. 48 Asia Pacific SWOT
  • Fig. 49 Latin America SWOT
  • Fig. 50 MEA SWOT
  • Fig. 51 North America, by country
  • Fig. 52 North America
  • Fig. 53 North America market estimates and forecast, 2018 - 2030
  • Fig. 54 U.S.
  • Fig. 55 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 56 Canada
  • Fig. 57 Canada market estimates and forecast, 2018 - 2030
  • Fig. 58 Europe
  • Fig. 59 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 60 UK
  • Fig. 61 UK market estimates and forecast, 2018 - 2030
  • Fig. 62 Germany
  • Fig. 63 Germany market estimates and forecast, 2018 - 2030
  • Fig. 64 France
  • Fig. 65 France market estimates and forecast, 2018 - 2030
  • Fig. 66 Italy
  • Fig. 67 Italy market estimates and forecast, 2018 - 2030
  • Fig. 68 Spain
  • Fig. 69 Spain market estimates and forecast, 2018 - 2030
  • Fig. 70 Sweden
  • Fig. 71 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 72 Norway
  • Fig. 73 Norway market estimates and forecast, 2018 - 2030
  • Fig. 74 Denmark
  • Fig. 75 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 76 Asia Pacific
  • Fig. 77 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 78 China
  • Fig. 79 China market estimates and forecast, 2018 - 2030
  • Fig. 80 Japan
  • Fig. 81 Japan market estimates and forecast, 2018 - 2030
  • Fig. 82 India
  • Fig. 83 India market estimates and forecast, 2018 - 2030
  • Fig. 84 Australia
  • Fig. 85 Australia market estimates and forecast, 2018 - 2030
  • Fig. 86 Thailand
  • Fig. 87 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 88 South Korea
  • Fig. 89 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 90 Latin America
  • Fig. 91 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 92 Brazil
  • Fig. 93 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 94 Mexico
  • Fig. 95 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 96 Argentina
  • Fig. 97 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 98 Middle East and Africa
  • Fig. 99 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 100 Saudi Arabia
  • Fig. 101 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 102 South Africa
  • Fig. 103 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 104 UAE
  • Fig. 105 UAE market estimates and forecast, 2018 - 2030
  • Fig. 106 Kuwait
  • Fig. 107 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 108 Participant categorization - Microneedle Drug Delivery Systems market
  • Fig. 109 Market share of key market players - Microneedle drug delivery systems market